Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neugranin vs Pegfilgrastim in Breast Cancer Chemotherapy-Induced Neutropenia
NCT00837265Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2008
- Primary completion
- Jun 2009
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of balugrastim in neutropenia, sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2008; status: completed.
02
Drugs
balugrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00837265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837265.